We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
-12.11%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$36.8B
AUM Growth
-$7.5B
Cap. Flow
-$811M
Cap. Flow %
-2.21%
Top 10 Hldgs %
13%
Holding
2,369
New
198
Increased
691
Reduced
1,095
Closed
239

Sector Composition

Rank Sector Weight
1 Healthcare 22.75%
2 Technology 14.79%
3 Financials 13.96%
4 Consumer Discretionary 7.59%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTC icon
1751
Evertec
EVTC
$1.88B
$23K ﹤0.01%
627
-32,837
-98% -$1.25M
PCRX icon
1752
Pacira BioSciences
PCRX
$1.04B
$23K ﹤0.01%
399
-80,543
-100% -$5.28M
RMAX icon
1753
RE/MAX Holdings
RMAX
$193M
$23K ﹤0.01%
954
-1,206
-56% -$29.3K
HWKN icon
1754
Hawkins
HWKN
$2.67B
$22K ﹤0.01%
615
-498
-45% -$18.8K
KPTI icon
1755
Karyopharm Therapeutics
KPTI
$43.5M
$22K ﹤0.01%
+329
New +$30.2K
LMND icon
1756
Lemonade
LMND
$3.74B
$22K ﹤0.01%
+1,217
New +$25.6K
NSIT icon
1757
Insight Enterprises
NSIT
$3.89B
$22K ﹤0.01%
261
-813
-76% -$79.4K
CDMO
1758
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$22K ﹤0.01%
1,461
-1,186
-45% -$17.5K
CDLX icon
1759
Cardlytics
CDLX
$21.7M
$21K ﹤0.01%
+93
New +$31.1K
WT icon
1760
WisdomTree
WT
$2.96B
$21K ﹤0.01%
4,073
-210,128
-98% -$1.21M
NXGN
1761
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$21K ﹤0.01%
1,185
-43,381
-97% -$827K
CHRS icon
1762
Coherus Oncology
CHRS
$217M
$20K ﹤0.01%
2,725
-2,214
-45% -$19.3K
MODV
1763
DELISTED
ModivCare
MODV
$20K ﹤0.01%
232
-190
-45% -$19.2K
PACB icon
1764
Pacific Biosciences
PACB
$435M
$20K ﹤0.01%
+4,609
New +$28K
PLTK icon
1765
Playtika
PLTK
$1.52B
$20K ﹤0.01%
+1,508
New +$23.5K
TTEC icon
1766
TTEC Holdings
TTEC
$121M
$20K ﹤0.01%
289
-235
-45% -$16.5K
TVTX icon
1767
Travere Therapeutics
TVTX
$5.2B
$20K ﹤0.01%
780
-86,154
-99% -$2.17M
RTL
1768
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$20K ﹤0.01%
2,717
-2,205
-45% -$16.6K
EWY icon
1769
iShares MSCI South Korea ETF
EWY
$21.9B
$19K ﹤0.01%
325
FLGT icon
1770
Fulgent Genetics
FLGT
$470M
$19K ﹤0.01%
353
-285
-45% -$15.7K
FRME icon
1771
First Merchants
FRME
$2.68B
$19K ﹤0.01%
528
-155
-23% -$6.1K
IRMD icon
1772
iRadimed
IRMD
$1.16B
$19K ﹤0.01%
559
-46
-8% -$1.65K
OGN icon
1773
Organon & Co
OGN
$3.56B
$19K ﹤0.01%
549
-12,181
-96% -$427K
OLMA icon
1774
Olema Pharmaceuticals
OLMA
$1B
$19K ﹤0.01%
4,565
+2,105
+86% +$6.68K
PATH icon
1775
UiPath
PATH
$6.61B
$19K ﹤0.01%
+979
New +$18.3K

Similar funds

Federated Hermes's Q2 2022 Portfolio in Review

As of Q2 2022, Federated Hermes held 2,369 positions worth $36.8B, down 17% from $44.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q2 2022 filing shows 198 new, 691 increased, 1,095 reduced and 239 closed positions. Its largest new stake was VICI Properties: 3,893,654 shares worth $116M. The largest sale was Chevron, an estimated $331M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

  • Federated Hermes's largest Q2 2022 buy was VICI Properties: 3,893,654 shares worth $116M.
  • Federated Hermes added most to PNC Financial Services in Q2 2022, an estimated $326M increase.
  • Federated Hermes's biggest Q2 2022 reduction was Chevron, cutting an estimated $331M.
  • Federated Hermes fully exited MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q2 2022, selling an estimated $121M.
  • Federated Hermes's ten largest holdings make up 13% of its $36.8B portfolio in Q2 2022.
  • Federated Hermes opened 198 new positions and closed 239 in Q2 2022.
  • Federated Hermes's portfolio value fell 17% quarter-over-quarter to $36.8B.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.